<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="2663">Amiodarone</z:chebi>, an <z:chebi fb="60" ids="24859">iodine</z:chebi>-rich drug, results in mild disturbances of thyroid function in most patients and in thyroid dysfunction in approximately 20% of them </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000821'>Hypothyroidism</z:hpo>, mainly found in countries without <z:chebi fb="60" ids="24859">iodine</z:chebi> deficiency, is substituted with <z:chebi fb="0" ids="18332">levothyroxine</z:chebi> and does not need <z:chebi fb="0" ids="2663">amiodarone</z:chebi> to be discontinued </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000836'>Hyperthyroidism</z:hpo>, commonly found in areas of <z:chebi fb="60" ids="24859">iodine</z:chebi> deficiency, is more complex and usually motivates discontinuation of <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Type I <z:hpo ids='HP_0000836'>hyperthyroidism</z:hpo>, induced by <z:chebi fb="60" ids="24859">iodine</z:chebi> overload, is treated with <z:chebi fb="0" ids="50671">antithyroid drugs</z:chebi>, and type 2, resulting from the cytotoxic effect of <z:chebi fb="0" ids="2663">amiodarone</z:chebi>, may be treated with <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Considering the risk of thyroid dysfunction in patients treated with <z:chebi fb="0" ids="2663">amiodarone</z:chebi>, it is recommended to check regularly TSH level </plain></SENT>
</text></document>